Analyst Sentiment Shifts as Arcellx Revenue Outlook Improves Analysts have upgraded Arcellx’s revenue forecasts for 2024, now expecting a 55% jump in sales and narrower losses. Despite recent volatility, optimism persists, with the company’s growth rate projected to outpace industry averages, reflecting increased confidence in its therapeutic pipeline and market prospects.23